An advisory panel to the Academy of Managed Care Pharmacy has begun an evaluation of gaps in addiction treatment services, with the goal of identifying both low-cost policy changes and more dramatic long-term actions to improve access to care.
“The epidemic of drug abuse and misuse represents one of the greatest challenges facing health care professionals today,” academy CEO Edith A. Rosato said in an Oct. 23 news release. She added, “It is imperative for pharmacists to play a central role in removing barriers for patients who seek medication assisted treatment (MAT) for drug addiction to have the best chance of obtaining a positive outcome.”
The academy's Addiction Treatment Advisory Group is being sponsored by organizations that include the managed behavioral healthcare organization group the Association for Behavioral Health and Wellness and pharmaceutical manufacturer Alkermes, Inc.
Other goals of the advisory group include developing recommendations for process and system improvements to enhance addiction treatment outcomes, sharing best practices, and playing an advocacy role in adoption of changes. The group is scheduled to meet monthly and to issue its findings and resource materials late next year.